Literature DB >> 23640862

Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment.

Stephen Y Xue1, Valeria Y Hebert, Danicia M Hayes, Corie N Robinson, Mitzi Glover, Tammy R Dugas.   

Abstract

Cardiovascular complications have been documented in HIV-1 infected populations, and antiretroviral therapy may play a role. Nucleoside reverse transcriptase inhibitors (NRTIs) are antiretrovirals known to induce mitochondrial damage in endothelial cells, culminating in endothelial dysfunction, an initiating event in atherogenesis. Though the mechanism for NRTI-induced endothelial toxicity is not yet clear, our prior work suggested that a mitochondrial oxidative stress may be involved. To further delineate the mechanism of toxicity, endothelial cells were treated with NRTIs of varying subclasses, and the level of reactive oxygen species (ROS) and mitochondrial function were assessed. To test whether rescue of mitochondrial electron transport attenuated NRTI-induced endothelial cytotoxicity, in some cases, cells were cotreated with the electron transport cofactor coenzyme Q10 (Q10). At 4-6h, NRTIs increased levels of ROS but decreased the activities of electron transport chain complexes I-IV, levels of ATP and the NAD/NADH ratio. Moreover, nitric oxide levels were decreased, whereas endothelin-1 release was increased. Q10 abolished NRTI-induced mitochondria injury and effects on endothelial agonist production. Interestingly, in cells treated with NRTIs only, markers for mitochondrial toxicity returned to baseline levels by 18-24h, suggesting a compensatory mechanism for clearing damaged mitochondria. Using confocal microscopy, with confirmation utilizing the autophagy and mitophagy markers LC-3 and Nix, respectively, we observed autophagy of mitochondria at 8-10h after treatment. Q10 prevented NRTI-mediated increase in LC-3. These findings suggest that NRTI-induced mitophagy may be involved in NRTI-induced endothelial dysfunction and that this damage likely results from oxidant injury. Further, Q10 supplementation could potentially prevent NRTI-induced endothelial dysfunction.

Entities:  

Keywords:  antiretrovirals; coenzyme Q10; endothelial dysfunction; mitochondria; mitophagy; nucleoside reverse transcriptase inhibitors; reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 23640862      PMCID: PMC3842105          DOI: 10.1093/toxsci/kft105

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  53 in total

Review 1.  Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.

Authors:  John Deanfield; Ann Donald; Claudio Ferri; Cristina Giannattasio; Julian Halcox; Sean Halligan; Amir Lerman; Giuseppe Mancia; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Ernesto L Schiffrin; Stefano Taddei; David J Webb
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

Review 2.  Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis.

Authors:  Paolo Puddu; Giovanni M Puddu; Livia Galletti; Eleonora Cravero; Antonio Muscari
Journal:  Cardiology       Date:  2005-01-19       Impact factor: 1.869

Review 3.  Signaling pathways in mitochondrial dysfunction and aging.

Authors:  Cristina Mammucari; Rosario Rizzuto
Journal:  Mech Ageing Dev       Date:  2010-07-24       Impact factor: 5.432

Review 4.  Autophagy: assays and artifacts.

Authors:  Sandra Barth; Danielle Glick; Kay F Macleod
Journal:  J Pathol       Date:  2010-06       Impact factor: 7.996

Review 5.  Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors.

Authors:  Gerald W Dorn
Journal:  J Cardiovasc Transl Res       Date:  2010-03-16       Impact factor: 4.132

6.  Endothelin-1 production is enhanced by rotenone, a mitochondrial complex I inhibitor, in cultured rat cardiomyocytes.

Authors:  K I Yuhki; T Miyauchi; Y Kakinuma; N Murakoshi; S Maeda; K Goto; I Yamaguchi; T Suzuki
Journal:  J Cardiovasc Pharmacol       Date:  2001-12       Impact factor: 3.105

7.  Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.

Authors:  Kaleb C Lund; LaRae L Peterson; Kendall B Wallace
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

8.  Coronary heart disease in HIV-infected individuals.

Authors:  Judith S Currier; Anne Taylor; Felicity Boyd; Christopher M Dezii; Hugh Kawabata; Beth Burtcel; Jen-Fue Maa; Sally Hodder
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-01       Impact factor: 3.731

9.  Adenosine 3',5'-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors.

Authors:  Kaleb C Lund; Kendall B Wallace
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-25       Impact factor: 4.219

10.  Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver.

Authors:  Varsha G Desai; Taewon Lee; Robert R Delongchamp; Julian E A Leakey; Sherry M Lewis; Fei Lee; Carrie L Moland; William S Branham; James C Fuscoe
Journal:  Mitochondrion       Date:  2008-02-01       Impact factor: 4.160

View more
  10 in total

1.  Increased coronary vessel wall thickness in HIV-infected young adults.

Authors:  Khaled Z Abd-Elmoniem; Aylin B Unsal; Sarah Eshera; Jatin R Matta; Nancy Muldoon; Dorothea McAreavey; Julia B Purdy; Rohan Hazra; Colleen Hadigan; Ahmed M Gharib
Journal:  Clin Infect Dis       Date:  2014-08-25       Impact factor: 9.079

2.  Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction.

Authors:  Mitzi Glover; Valeria Y Hebert; Krystle Nichols; Stephen Y Xue; Taylor M Thibeaux; James A Zavecz; Tammy R Dugas
Journal:  Antiviral Res       Date:  2014-09-27       Impact factor: 5.970

3.  Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells.

Authors:  Lin Song; Sha Ding; Zhen Ge; Xiaolong Zhu; Cong Qiu; Yuewen Wang; Enyin Lai; Weijun Yang; Yi Sun; Samson A Chow; Luyang Yu
Journal:  Br J Pharmacol       Date:  2017-10-25       Impact factor: 8.739

Review 4.  Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV Therapeutics.

Authors:  Ashley D Holec; Subhra Mandal; Pavan Kumar Prathipati; Christopher J Destache
Journal:  Curr HIV Res       Date:  2017       Impact factor: 1.581

5.  Mitochondrial compromise in 3-year old patas monkeys exposed in utero to human-equivalent antiretroviral therapies.

Authors:  Yongmin Liu; Eunwoo Shim Park; Alexander T Gibbons; Eric D Shide; Rao L Divi; Ruth A Woodward; Miriam C Poirier
Journal:  Environ Mol Mutagen       Date:  2016-07-25       Impact factor: 3.216

Review 6.  Drug-Induced Mitochondrial Toxicity.

Authors:  Iain P Hargreaves; Mesfer Al Shahrani; Luke Wainwright; Simon J R Heales
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

7.  Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy.

Authors:  Justin T Morrison; Chris T Longenecker; Alison Mittelsteadt; Ying Jiang; Sara M Debanne; Grace A McComsey
Journal:  HIV Clin Trials       Date:  2016-06-13

8.  Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity.

Authors:  Reuben L Smith; Josephine M E Tan; Martijs J Jonker; Aldo Jongejan; Thomas Buissink; Steve Veldhuijzen; Antoine H C van Kampen; Stanley Brul; Hans van der Spek
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 9.  Antiretroviral Drugs Impact Autophagy with Toxic Outcomes.

Authors:  Laura Cheney; John M Barbaro; Joan W Berman
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

Review 10.  Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson's Disease.

Authors:  Michał Rakowski; Szymon Porębski; Agnieszka Grzelak
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.